World Journal of Personalized Medicine

Advanced search

For citations:

Ivashchenko D.V., Ryzhykova K.A., Sozaeva Z.A., Zastrozhin M.S., Grishina E.A., Savchenko L.M., Bryun E.A., Sychev D.A. Pharmacogenetic evaluation of adverse events’ risk in patients with alcohol withdrawal syndrome taking bromdihydrochlorphenylbenzodiazepine: The role of CYP2C19 gene polymorphisms. World Journal of Personalized Medicine. 2017;1(1):18-26. (In Russ.)

Views: 33

ISSN 2587-733X (Online)